From January 1, 2022 to January 19, 2022, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 2,273,523 shares, representing 1.44% for CNY 79.31 million under the buyback announced on January 21, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.15 CNY | -1.37% | -2.17% | -20.82% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.82% | 673M | |
+34.35% | 693B | |
+29.39% | 584B | |
-3.49% | 372B | |
+20.15% | 332B | |
+6.19% | 294B | |
+14.11% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+9.21% | 168B |
- Stock Market
- Equities
- 603590 Stock
- News Beijing Konruns Pharmaceutical Co.,Ltd.
- Tranche Update on Beijing Konruns Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on January 21, 2021.